Müllerian inhibiting substance: an instructive developmental hormone with diagnostic and possible therapeutic applications.
about
sameAs
The anti-Müllerian hormone type II receptor: insights into the binding domains recognized by a monoclonal antibody and the natural ligandMüllerian inhibiting substance contributes to sex-linked biases in the brain and behaviorAnti-Mullerian Hormone: Above and Beyond Conventional Ovarian Reserve MarkersRole of Anti-Müllerian Hormone in pathophysiology, diagnosis and treatment of Polycystic Ovary Syndrome: a reviewMolecular players involved in temperature-dependent sex determination and sex differentiation in Teleost fishMammalian target of rapamycin is a therapeutic target for murine ovarian endometrioid adenocarcinomas with dysregulated Wnt/β-catenin and PTENSmad1-Smad5 ovarian conditional knockout mice develop a disease profile similar to the juvenile form of human granulosa cell tumors.Hyperplasia and fibrosis in mice with conditional loss of the TSC2 tumor suppressor in Müllerian duct mesenchyme-derived myometria.Deletion of tuberous sclerosis 1 in somatic cells of the murine reproductive tract causes female infertility.Expression of the Ladybird-like homeobox 2 transcription factor in the developing mouse testis and epididymisExpression of activated PIK3CA in ovarian surface epithelium results in hyperplasia but not tumor formation.Constitutive WNT/beta-catenin signaling in murine Sertoli cells disrupts their differentiation and ability to support spermatogenesisEndometrial cancer is a receptor-mediated target for Mullerian Inhibiting SubstanceInduction of WNT inhibitory factor 1 expression by Müllerian inhibiting substance/antiMullerian hormone in the Müllerian duct mesenchyme is linked to Müllerian duct regression.Regulation and expression of sexual differentiation factors in embryonic and extragonadal tissues of Atlantic salmon.Assay reproducibility and within-person variation of Müllerian inhibiting substance.Serum Müllerian inhibiting substance levels are lower in premenopausal women with breast precancer and cancer.Mullerian inhibiting substance suppresses tumor growth in the C3(1)T antigen transgenic mouse mammary carcinoma modelGranulosa cell-specific androgen receptors are critical regulators of ovarian development and function.Mullerian inhibiting substance acts as a motor neuron survival factor in vitro.Focal Mullerian duct retention in male mice with constitutively activated beta-catenin expression in the Mullerian duct mesenchymeMüllerian inhibiting substance/anti-Müllerian hormone: A novel treatment for gynecologic tumorsGenetic variants in anti-Mullerian hormone and anti-Mullerian hormone receptor genes and breast cancer risk in Caucasians and African AmericansMullerian inhibiting substance inhibits invasion and migration of epithelial cancer cell lines.β-Catenin is essential for Müllerian duct regression during male sexual differentiation.UK guidance on the initial evaluation of an infant or an adolescent with a suspected disorder of sex developmentHow to evaluate gonadal function in the cryptorchid boy. Lessons from new testicular markers.Normal and abnormal epithelial differentiation in the female reproductive tract.Regulation of gonadotropin gene expression by Mullerian inhibiting substance.Adenomatous polyposis coli (APC) is essential for maintaining the integrity of the seminiferous epithelium.Serum anti-Müllerian hormone as a predictive marker of polycystic ovarian syndrome.Expression of MIS in the testis is downregulated by tumor necrosis factor alpha through the negative regulation of SF-1 transactivation by NF-kappa B.Smad4 overexpression causes germ cell ablation and leydig cell hyperplasia in transgenic mice.Assessment of the relationship of basal serum anti-mullerian hormone levels with oocyte quality and pregnancy outcomes in patients undergoing ICSIA Y-linked anti-Müllerian hormone duplication takes over a critical role in sex determinationEffects of GnRH agonists on the expression of developmental follicular anti-mullerian hormone in varying follicular stages in cyclic mice in vivo.The human Müllerian inhibiting substance type II receptor as immunotherapy target for ovarian cancer. Validation using the mAb 12G4.c-Jun N-terminal kinase inhibitor II (SP600125) activates Mullerian inhibiting substance type II receptor-mediated signal transduction.The Müllerian inhibiting substance type 2 receptor suppresses tumorigenesis in testes with sustained β-catenin signalingAnti-Müllerian hormone (AMH) in female reproduction: is measurement of circulating AMH a useful tool?
P2860
Q24306670-4EE17B2B-6C6F-4921-8E4D-A70B10CF4645Q24306670-667DCF65-FBFC-4D20-BF84-81BAC7BAC1BFQ24648962-419C7EC6-EB3D-40AE-8FDD-D46388FB92ABQ24648962-A290AD17-F83A-4306-9A38-01741309D6B7Q26765770-03EE1957-CB8E-4AA6-8E45-621E48C0149BQ26765770-81EBC05D-4008-4755-B637-37761187C7F1Q26774060-09DE6824-E379-43E8-BC0E-8D34A811EE40Q26774060-6F89B819-295B-419F-B9C6-5E4098C383F9Q26849657-6F113F4D-1B81-4EBA-8442-23617BB5727DQ26849657-E9A899D5-5DB3-4363-91DD-DE2F9EB46035Q27335766-7CBB9B1C-6588-4139-9732-7B1A20A418C5Q27335766-F87467D5-67D4-49B3-B782-A00937690E23Q30040477-5B6CC2C1-0B83-4018-9C97-E4E90DD830E9Q30040477-5DD707BB-7B2D-407E-BCFC-EAECF4014F79Q30370194-99E93C81-9027-4865-BD06-5B5F8385F0EFQ30370194-F6A58244-D138-4373-B653-DBC7204B981FQ30423103-7D13C998-4B4B-40B9-9FE8-53E8FE78945FQ30423103-CA0F7F62-9746-4EDF-A637-D8A76AF67F9BQ30443270-C6832B96-F154-4551-B07A-7A19522CA43AQ30443270-FEBD2BC4-77B9-4C33-A9CF-5EB1704F0139Q33403197-4EED5FC0-AE16-4C2B-B4ED-B519BC24E446Q33403197-97102F29-F1D5-45E2-B25B-30010DA9ADA4Q33601965-83184443-1633-479B-B595-29CAB16F8378Q33601965-A093B6D0-25B1-4352-BE34-E97BB0AAA787Q33716008-5BFD4494-0A78-4B22-873A-DA643CB4E857Q33716008-D96507A7-C239-4C2F-9077-2D8BFDAD058DQ33719519-6B9199CF-1B97-401C-B6F7-DF9B28753A55Q33719519-72A9AAF5-6BE8-49CD-82A7-F5568057839AQ33792663-2A3D48DE-A4DA-4D2A-81F4-A971BCFA28A4Q33792663-2EEB8A3B-4DFD-4836-8A90-564EF24806B1Q33875907-4A942B00-85A8-46DC-A900-B7A5AEE749E1Q33875907-E0D0935A-6A59-4E9E-B267-49BAFEE60D58Q33912912-62C715F0-B1E4-4F53-98A0-03875166DDADQ33912912-6CA5D9CB-6E73-4383-BA63-59850F64959BQ33927553-14B92DCC-82F2-4B8A-BB1C-4BE3B5E87D3FQ33927553-C99376F3-22C7-4C8E-8B17-393FF02952DDQ33993659-8E1747F5-C157-4B36-BE1E-0908480962F8Q33993659-BFC1F98B-2619-4A69-BB27-CA7779806199Q34132471-054AA4F4-1351-4B1D-BB76-97EA38591B0BQ34132471-6D864082-216F-4520-B72A-9CA8B2A9ED6F
P2860
Müllerian inhibiting substance: an instructive developmental hormone with diagnostic and possible therapeutic applications.
description
2001 nî lūn-bûn
@nan
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Müllerian inhibiting substance ...... ible therapeutic applications.
@ast
Müllerian inhibiting substance ...... ible therapeutic applications.
@en
Müllerian inhibiting substance ...... ible therapeutic applications.
@nl
type
label
Müllerian inhibiting substance ...... ible therapeutic applications.
@ast
Müllerian inhibiting substance ...... ible therapeutic applications.
@en
Müllerian inhibiting substance ...... ible therapeutic applications.
@nl
altLabel
Müllerian Inhibiting Substance ...... sible Therapeutic Applications
@en
Müllerian Inhibiting Substance ...... sible Therapeutic Applications
@nl
prefLabel
Müllerian inhibiting substance ...... ible therapeutic applications.
@ast
Müllerian inhibiting substance ...... ible therapeutic applications.
@en
Müllerian inhibiting substance ...... ible therapeutic applications.
@nl
P2093
P1433
P1476
Müllerian Inhibiting Substance ...... sible Therapeutic Applications
@en
Müllerian inhibiting substance ...... ible therapeutic applications.
@en
P2093
J Teixeira
Jose Teixeira
P K Donahoe
Patricia K. Donahoe
S Maheswaran
Shyamala Maheswaran
P304
P356
10.1210/EDRV.22.5.0445
10.1210/ER.22.5.657
P577
2001-10-01T00:00:00Z